Brian Skorney
Baird Equity Research
Tazeen Ahmad
Bank of America Securities
Carter Gould
Barclays
Evan Seigerman
BMO Capital Markets
Sumant Kulkarni
Canaccord Genuity
Charles Duncan
Cantor Fitzgerald
Phil Nadeau
TD Cowen
Chris Shibutani
Goldman Sachs
Yatin Suneja
Guggenheim Securities, LLC
Andrew Fein
H.C. Wainwright & Co.
Akash Tewari
Jefferies LLC
Anupam Rama
J.P. Morgan
Uy Ear
Mizuho Securities USA LLC
Jeffrey Hung
Morgan Stanley
Ami Fadia
Needham
Jay Olson
Oppenheimer
David Ansellem
Piper Sandler
Brian Abrahams
RBC Capital Markets, LLC
Danielle Brill
Raymond James
Paul Matteis
Stifel
Marc Goodman
Leerink Partners
Ash Verma
UBS
Laura Chico
Wedbush Securities
Mohit Bansal
Wells Fargo
Myles Minter
William Blair
Neurocrine Biosciences is followed by the analysts listed. Please note that any opinions, estimates or forecasts regarding Neurocrine Biosciences's performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Neurocrine Biosciences or its management. Neurocrine Biosciences does not by its reference or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.